Patents by Inventor Bernard Masereel

Bernard Masereel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta carboline derivatives useful in the treatment of proliferative disorders
    Patent number: 9168247
    Abstract: The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: October 27, 2015
    Assignees: FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX, UNIVERSITE LIBRE BRUXELLES
    Inventors: Raphael Frederick, Bernard Masereel, Jeremy Reniers, Johan Wouters, Celine Bruyere, Robert Kiss, Céline Anne Marie Michelle Meinguet, Véronique Emmanuelle Julie Mathieu
  • BETA CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS
    Publication number: 20140005220
    Abstract: The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.
    Type: Application
    Filed: June 24, 2011
    Publication date: January 2, 2014
    Applicants: UNIVERSITE LIBRE DE BRUXELLES, FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX
    Inventors: Raphael Frederick, Bernard Masereel, Jeremy Reniers, Johan Wouters, Celine Bruyere, Robert Kiss
  • BETA CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS
    Publication number: 20130116273
    Abstract: The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.
    Type: Application
    Filed: June 24, 2011
    Publication date: May 9, 2013
    Applicants: UNIVERSITE LIBRE DE BRUXELLES, FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX
    Inventors: Raphael Frederick, Bernard Masereel, Jeremy Reniers, Johan Wouters, Celine Bruyere, Robert Kiss
  • Benzene-sulphonamide derivatives and their uses
    Patent number: 6818765
    Abstract: Benzene-sulphonamide derivatives complying with the general formula (I): in which the different symbols have different meanings, their optical isomers and the salts pharmacologically acceptable of these derivatives, as well as their uses for drug manufacture and as radiolabelled pharmacological tools of the thromboxan A2 receptors.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: November 16, 2004
    Assignee: Universite de Liege
    Inventors: Jacques Delarge, Jean-Michel Dogne, Bernard Masereel
  • Pyridothiadiazines
    Patent number: 5459138
    Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which A, R.sub.1, R.sub.2 and R.sub.4 are as defined in the description,and medicinal products containing the same which is useful for treating a pathology related to dysfunctioning of glutamatergic neurotransmission.
    Type: Grant
    Filed: March 24, 1994
    Date of Patent: October 17, 1995
    Assignee: Adir et Compagnie
    Inventors: Bernard Pirotte, Pascal de Tullio, Bernard Masereel, Jacques Delarge, Jean Lepagnol, Pierre Renard
  • New pyridylsulphonylurea compound
    Patent number: 5391559
    Abstract: The invention relates to the compound of formula (I) ##STR1## and the addition salts thereof with a pharmaceutically acceptable acid or base.A pharmaceutical product which is useful for treating an ischemic or hypoxic disorder or a peripheral or central oedema.
    Type: Grant
    Filed: January 5, 1993
    Date of Patent: February 21, 1995
    Assignee: Adir et Compagnie
    Inventors: Bernard Masereel, Bernard Pirotte, Marc Schynts, Jacques Delarge
  • Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
    Patent number: 5166162
    Abstract: The invention concerns a compound of formula (I) ##STR1## in which: R represents cycloalkyl, bicycloalkyl or polycycloalkyl,X represents oxygen or sulfur, andR1 represents alkyl, cycloalkyl, bicycloalkyl, or polycycloalkyl.Medicaments thereof and use of same is useful in treating a circulatory ailment related to arterial hypertension or peripheral or cerebral oedema.
    Type: Grant
    Filed: January 24, 1992
    Date of Patent: November 24, 1992
    Assignee: Adir et Compagnie
    Inventors: Bernard Masereel, Bernard Pirotte, Marc Schynts, Jacques Delarge